51.03
0.39%
0.20
Inari Medical Inc stock is traded at $51.03, with a volume of 426.41K.
It is up +0.39% in the last 24 hours and up +16.77% over the past month.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
See More
Previous Close:
$50.83
Open:
$51.1
24h Volume:
426.41K
Relative Volume:
0.50
Market Cap:
$2.97B
Revenue:
$574.50M
Net Income/Loss:
$-78.58M
P/E Ratio:
-850.50
EPS:
-0.06
Net Cash Flow:
$1.58M
1W Performance:
+4.14%
1M Performance:
+16.77%
6M Performance:
+2.16%
1Y Performance:
-12.65%
Inari Medical Inc Stock (NARI) Company Profile
Name
Inari Medical Inc
Sector
Industry
Phone
949-923-4747
Address
6001 OAK CANYON, SUITE 100, IRVINE, CA
Compare NARI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
NARI
Inari Medical Inc
|
51.03 | 2.97B | 574.50M | -78.58M | 1.58M | -0.06 |
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Inari Medical Inc Stock (NARI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-18-24 | Initiated | Stifel | Hold |
Sep-03-24 | Initiated | Leerink Partners | Market Perform |
Aug-09-24 | Initiated | Deutsche Bank | Buy |
Jul-25-24 | Initiated | William Blair | Outperform |
Jul-18-24 | Downgrade | Needham | Buy → Hold |
Feb-29-24 | Downgrade | Piper Sandler | Overweight → Neutral |
Jan-23-24 | Initiated | Needham | Buy |
Jul-19-23 | Initiated | Robert W. Baird | Outperform |
Oct-12-22 | Initiated | Jefferies | Buy |
Sep-29-22 | Initiated | Berenberg | Buy |
Sep-13-22 | Initiated | Truist | Hold |
Jun-21-22 | Initiated | Piper Sandler | Overweight |
Mar-23-22 | Resumed | BofA Securities | Buy |
Dec-15-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Nov-18-20 | Initiated | BTIG Research | Buy |
Oct-29-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Sep-28-20 | Initiated | SVB Leerink | Outperform |
Jun-19-20 | Initiated | Canaccord Genuity | Buy |
Jun-16-20 | Initiated | BofA/Merrill | Neutral |
Jun-16-20 | Initiated | Morgan Stanley | Equal-Weight |
Jun-16-20 | Initiated | Wells Fargo | Equal Weight |
View All
Inari Medical Inc Stock (NARI) Latest News
Leerink Partnrs Expects Reduced Earnings for Inari Medical - MarketBeat
Dynamic Technology Lab Private Ltd Invests $1.40 Million in Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat
Millrace Asset Group Inc. Has $286,000 Stock Holdings in Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat
Inari Medical FY2027 EPS Estimate Reduced by Leerink Partnrs - MarketBeat
(NARI) Investment Analysis - Stock Traders Daily
Ontario Teachers Pension Plan Board Reduces Holdings in Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat
Brown Capital Management LLC Decreases Position in Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat
Jennison Associates LLC Acquires 610,468 Shares of Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat
Inari medical director William Hoffman sells $3.07m in stock By Investing.com - Investing.com South Africa
Inari medical director William Hoffman sells $3.07m in stock - Investing.com
Inari Medical stock tumbles 18% amid news of DOJ probe - MSN
Inari Medical Inc (NARI) Shares Down 4.67% on Nov 20 - GuruFocus.com
LMR Partners LLP Has $1.11 Million Stock Holdings in Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat
First Week of January 2025 Options Trading For Inari Medical (NARI) - Nasdaq
Inari Medical, Inc. (NASDAQ:NARI) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Inari Medical (NASDAQ:NARI) Trading Up 4.3%Should You Buy? - MarketBeat
10,369 Shares in Inari Medical, Inc. (NASDAQ:NARI) Acquired by Aigen Investment Management LP - MarketBeat
Trend Tracker for (NARI) - Stock Traders Daily
Fiera Capital Corp Sells 19,821 Shares of Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat
NARIInari Medical, Inc. Latest Stock News & Market Updates - StockTitan
Is Inari Medical (NARI) Trading at an Attractive Valuation? - Yahoo Finance
Inari Medical, Inc. (NASDAQ:NARI) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable - Simply Wall St
Financial Enhancement Group LLC Acquires Shares of 28,002 Inari Medical, Inc. (NASDAQ:NARI) - MarketBeat
Inari Medical to Participate in the Jefferies London Healthcare Conference - The Manila Times
Inari Medical to Present at Jefferies London Healthcare Conference 2024 | NARI Stock News - StockTitan
Inari Medical FY2025 EPS Estimate Boosted by William Blair - MarketBeat
(NARI) Proactive Strategies - Stock Traders Daily
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday - MSN
Director William Hoffman Sells 40,000 Shares of Inari Medical In - GuruFocus.com
Inari medical director William Hoffman sells $2 million in stock By Investing.com - Investing.com Canada
Inari Medical CEO Andrew Hykes sells $150,000 in stock - Investing.com India
Inari Medical CEO Andrew Hykes sells $150,000 in stock By Investing.com - Investing.com Canada
Inari medical director William Hoffman sells $2 million in stock - Investing.com
Inari Medical shares hold as Canaccord affirms Buy rating By Investing.com - Investing.com Australia
Leerink Partnrs Expects Stronger Earnings for Inari Medical - MarketBeat
Inari Medical shares hold as Canaccord affirms Buy rating - Investing.com
Piper Sandler raises Inari Medical stock target on strong Q3 revenue - Investing.com Australia
Inari Medical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Inari Medical FY2026 EPS Estimate Cut by Leerink Partnrs - MarketBeat
Inari Medical Q3 Earnings Miss Estimates, Revenues Increase Y/Y - MSN
BTIG keeps Buy rating on Inari shares, upbeat following beat-and-raise Q3 - Investing.com Canada
Inari Medical Inc (NARI) Q3 2024 Earnings: Revenue Hits $153M, E - GuruFocus.com
Inari Medical Q3 2024 Earnings Preview - MSN
Inari Medical stock target boosted on profit beat, Hold rating upheld By Investing.com - Investing.com South Africa
BTIG keeps Buy rating on Inari shares, upbeat following beat-and-raise Q3 By Investing.com - Investing.com South Africa
Inari Medical stock price target raised on strong growth outlook By Investing.com - Investing.com South Africa
Piper Sandler raises Inari Medical stock target on strong Q3 revenue By Investing.com - Investing.com South Africa
Inari Medical, Hertz Global, Fastly, and Ryvyl Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - GlobeNewswire
Inari Medical, Hertz Global, Fastly, and Ryvyl Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - GlobeNewswire Inc.
Earnings call: Inari Medical posts record revenue in Q3, aims for profitability By Investing.com - Investing.com South Africa
Earnings call: Inari Medical posts record revenue in Q3, aims for profitability - Investing.com Australia
Inari Medical Inc Stock (NARI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):